Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 24,767 shares at $41.80 ($1.0M) on 2015-10-23, disclosed to the SEC on 2015-10-27.
Scheduled sale ($1.0M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.80 | 940 | $39K | 3.8% |
| 2 | $41.80 | 11,491 | $480K | 46.4% |
| 3 | $41.80 | 5,038 | $211K | 20.3% |
| 4 | $41.80 | 7,298 | $305K | 29.5% |
| Total | $41.80 avg | 24,767 | $1.0M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |